Contact
Please use this form to send email to PR contact of this press release:
GSK receives positive CHMP opinion for Incruse® (umeclidinium) for the treatment of COPD
TO:
Please use this form to send email to PR contact of this press release:
GSK receives positive CHMP opinion for Incruse® (umeclidinium) for the treatment of COPD
TO: